La Jolla Pharmaceutical Balance Sheet Health
Financial Health criteria checks 0/6
La Jolla Pharmaceutical has a total shareholder equity of $-69.5M and total debt of $124.5M, which brings its debt-to-equity ratio to -179.3%. Its total assets and total liabilities are $99.4M and $168.8M respectively.
Key information
-179.3%
Debt to equity ratio
US$124.54m
Debt
Interest coverage ratio | n/a |
Cash | US$48.66m |
Equity | -US$69.47m |
Total liabilities | US$168.83m |
Total assets | US$99.37m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LJPP has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: LJPP has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: LJPP has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: LJPP's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: LJPP's debt is not well covered by operating cash flow (10.5%).
Interest Coverage: Insufficient data to determine if LJPP's interest payments on its debt are well covered by EBIT.